Licensed as a psychiatric nurse practitioner more than 20 years ago, I thought I’d never need or want to prescribe lithium. Old school, I thought. A 1950s drug; we have much better now. It’s true, ...

According to recent data from the Global Bipolar Cohort, only 29% of people with bipolar disorder are prescribed lithium. Despite being the "gold standard" for treating this mental health condition, ...

Lithium side effects may include diarrhea, rash, hair thinning, weight gain, and more. Lithium is a mood stabilizer used to treat bipolar disorder, a condition that involves episodes of depression, ...

ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for ...

Although lithium is highly effective to treat bipolar disorder, the chemical has a narrow therapeutic window—too high a dose can be toxic to patients, causing kidney damage, thyroid damage, or even ...

A new study has found that early treatment with lithium can restore brain function and alleviate behavioral symptoms in mouse models of autism spectrum disorder (ASD) stemming from mutations in the ...

ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for ...

Low-dose lithium can block an enzyme linked to cellular aging and functional decline in the kidneys. The corresponding study was published in The Journal of Clinical Investigation. Although commonly ...

New research indicates lithium, used to treat bipolar disorder and depression, could also combat dementia, which affects 982,000 people in the UK and for which there is no cure.

Harvard University Associate Professor, Dr. Ovidiu Andronesi MD, PhD, will be the principal investigator of the study Head-to-head study of AL001 versus a marketed lithium carbonate product will be ...

ATLANTA--(BUSINESS WIRE)-- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for ...